Evidence map›Paper›PMID 30652537›Full record

ArticleJCO clinical cancer informatics2018

Incorporating Digital Tools to Improve Clinical Trial Infrastructure: A White Paper From the Digital Engagement Committee of SWOG.

Don S Dizon, Mina S Sedrak, Mark A Lewis, Elise Cook, Michael J Fisch, Jennifer R Klemp, Jonathan Sommers, AnneMarie Ciccarella, Julie Gralow, Wendy Lawton and 2 more

Abstract readConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Article in JCO clinical cancer informatics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Don S DizonDon S. Dizon, Lifespan Cancer Institute, Providence, RI; Mina S. Sedrak, City of Hope National Medical Center, Duarte, CA; Mark A. Lewis and Craig Nichols, Intermountain Medical Center, Murray, UT; Elise Cook and Michael J. Fisch, The University of Texas MD Anderson Cancer Center, Houston, TX; Jennifer R. Klemp, University of Kansas Medical Center, Kansas City, KS; Julie Gralow, University of Washington Medical Center, Seattle, WA; Wendy Lawton, Oregon Health and Science University, Portland, OR; and Jonathan Sommers and AnneMarie Ciccarella, Patient Advocates, SWOG Digital Engagement Committee.
Mina S SedrakDon S. Dizon, Lifespan Cancer Institute, Providence, RI; Mina S. Sedrak, City of Hope National Medical Center, Duarte, CA; Mark A. Lewis and Craig Nichols, Intermountain Medical Center, Murray, UT; Elise Cook and Michael J. Fisch, The University of Texas MD Anderson Cancer Center, Houston, TX; Jennifer R. Klemp, University of Kansas Medical Center, Kansas City, KS; Julie Gralow, University of Washington Medical Center, Seattle, WA; Wendy Lawton, Oregon Health and Science University, Portland, OR; and Jonathan Sommers and AnneMarie Ciccarella, Patient Advocates, SWOG Digital Engagement Committee.
Mark A LewisDon S. Dizon, Lifespan Cancer Institute, Providence, RI; Mina S. Sedrak, City of Hope National Medical Center, Duarte, CA; Mark A. Lewis and Craig Nichols, Intermountain Medical Center, Murray, UT; Elise Cook and Michael J. Fisch, The University of Texas MD Anderson Cancer Center, Houston, TX; Jennifer R. Klemp, University of Kansas Medical Center, Kansas City, KS; Julie Gralow, University of Washington Medical Center, Seattle, WA; Wendy Lawton, Oregon Health and Science University, Portland, OR; and Jonathan Sommers and AnneMarie Ciccarella, Patient Advocates, SWOG Digital Engagement Committee.
Elise CookDon S. Dizon, Lifespan Cancer Institute, Providence, RI; Mina S. Sedrak, City of Hope National Medical Center, Duarte, CA; Mark A. Lewis and Craig Nichols, Intermountain Medical Center, Murray, UT; Elise Cook and Michael J. Fisch, The University of Texas MD Anderson Cancer Center, Houston, TX; Jennifer R. Klemp, University of Kansas Medical Center, Kansas City, KS; Julie Gralow, University of Washington Medical Center, Seattle, WA; Wendy Lawton, Oregon Health and Science University, Portland, OR; and Jonathan Sommers and AnneMarie Ciccarella, Patient Advocates, SWOG Digital Engagement Committee.
Michael J FischDon S. Dizon, Lifespan Cancer Institute, Providence, RI; Mina S. Sedrak, City of Hope National Medical Center, Duarte, CA; Mark A. Lewis and Craig Nichols, Intermountain Medical Center, Murray, UT; Elise Cook and Michael J. Fisch, The University of Texas MD Anderson Cancer Center, Houston, TX; Jennifer R. Klemp, University of Kansas Medical Center, Kansas City, KS; Julie Gralow, University of Washington Medical Center, Seattle, WA; Wendy Lawton, Oregon Health and Science University, Portland, OR; and Jonathan Sommers and AnneMarie Ciccarella, Patient Advocates, SWOG Digital Engagement Committee.
Jennifer R KlempDon S. Dizon, Lifespan Cancer Institute, Providence, RI; Mina S. Sedrak, City of Hope National Medical Center, Duarte, CA; Mark A. Lewis and Craig Nichols, Intermountain Medical Center, Murray, UT; Elise Cook and Michael J. Fisch, The University of Texas MD Anderson Cancer Center, Houston, TX; Jennifer R. Klemp, University of Kansas Medical Center, Kansas City, KS; Julie Gralow, University of Washington Medical Center, Seattle, WA; Wendy Lawton, Oregon Health and Science University, Portland, OR; and Jonathan Sommers and AnneMarie Ciccarella, Patient Advocates, SWOG Digital Engagement Committee.
Jonathan SommersDon S. Dizon, Lifespan Cancer Institute, Providence, RI; Mina S. Sedrak, City of Hope National Medical Center, Duarte, CA; Mark A. Lewis and Craig Nichols, Intermountain Medical Center, Murray, UT; Elise Cook and Michael J. Fisch, The University of Texas MD Anderson Cancer Center, Houston, TX; Jennifer R. Klemp, University of Kansas Medical Center, Kansas City, KS; Julie Gralow, University of Washington Medical Center, Seattle, WA; Wendy Lawton, Oregon Health and Science University, Portland, OR; and Jonathan Sommers and AnneMarie Ciccarella, Patient Advocates, SWOG Digital Engagement Committee.
AnneMarie CiccarellaDon S. Dizon, Lifespan Cancer Institute, Providence, RI; Mina S. Sedrak, City of Hope National Medical Center, Duarte, CA; Mark A. Lewis and Craig Nichols, Intermountain Medical Center, Murray, UT; Elise Cook and Michael J. Fisch, The University of Texas MD Anderson Cancer Center, Houston, TX; Jennifer R. Klemp, University of Kansas Medical Center, Kansas City, KS; Julie Gralow, University of Washington Medical Center, Seattle, WA; Wendy Lawton, Oregon Health and Science University, Portland, OR; and Jonathan Sommers and AnneMarie Ciccarella, Patient Advocates, SWOG Digital Engagement Committee.
Julie GralowDon S. Dizon, Lifespan Cancer Institute, Providence, RI; Mina S. Sedrak, City of Hope National Medical Center, Duarte, CA; Mark A. Lewis and Craig Nichols, Intermountain Medical Center, Murray, UT; Elise Cook and Michael J. Fisch, The University of Texas MD Anderson Cancer Center, Houston, TX; Jennifer R. Klemp, University of Kansas Medical Center, Kansas City, KS; Julie Gralow, University of Washington Medical Center, Seattle, WA; Wendy Lawton, Oregon Health and Science University, Portland, OR; and Jonathan Sommers and AnneMarie Ciccarella, Patient Advocates, SWOG Digital Engagement Committee.
Wendy LawtonDon S. Dizon, Lifespan Cancer Institute, Providence, RI; Mina S. Sedrak, City of Hope National Medical Center, Duarte, CA; Mark A. Lewis and Craig Nichols, Intermountain Medical Center, Murray, UT; Elise Cook and Michael J. Fisch, The University of Texas MD Anderson Cancer Center, Houston, TX; Jennifer R. Klemp, University of Kansas Medical Center, Kansas City, KS; Julie Gralow, University of Washington Medical Center, Seattle, WA; Wendy Lawton, Oregon Health and Science University, Portland, OR; and Jonathan Sommers and AnneMarie Ciccarella, Patient Advocates, SWOG Digital Engagement Committee.
Craig NicholsDon S. Dizon, Lifespan Cancer Institute, Providence, RI; Mina S. Sedrak, City of Hope National Medical Center, Duarte, CA; Mark A. Lewis and Craig Nichols, Intermountain Medical Center, Murray, UT; Elise Cook and Michael J. Fisch, The University of Texas MD Anderson Cancer Center, Houston, TX; Jennifer R. Klemp, University of Kansas Medical Center, Kansas City, KS; Julie Gralow, University of Washington Medical Center, Seattle, WA; Wendy Lawton, Oregon Health and Science University, Portland, OR; and Jonathan Sommers and AnneMarie Ciccarella, Patient Advocates, SWOG Digital Engagement Committee.
SWOG Digital Engagement Committee

Funding

SWOG Network Group Operations Center of the NCTNU10CA180888 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI PRIMO N. LARA · 2014 to 2026
$152.1M
SWOG NCORP Research BaseUG1CA189974 · NCI · THE HOPE FOUNDATION · PI CHARLES D. BLANKE, DAWN HERSHMAN · 2014 to 2026
$80.6M
NCI NIH HHS U10 CA180888NCI NIH HHS UG1 CA189974
6 · The paper itself

Abstract

Progress toward improvement in cancer therapy relies on clinical trials. Yet, only a minority of eligible patients with cancer enroll as a result of multiple barriers at the patient, investigator, center, and national level. However, the rise of the Internet and mobile technology has created a slew of tools with medical applications, from Web sites to apps to social media platforms, all of which may aide clinicians in our quest to improve the clinical research enterprise. SWOG is one of five members in the National Cancer Institute's National Clinical Trials Network-the nation's oldest and largest publicly funded cancer research network-and is taking a leadership role in exploring and testing the promise of digital engagement through the empaneling of the Digital Engagement Committee. This article outlines the mission, principles, and priorities of the Digital Engagement Committee and proposes how this work may inform the use of digital tools for the cancer research community and, hopefully, translate to improved outcomes for our patients.

Indexed as

Access to InformationClinical Trials as TopicHumansInternetNational Cancer Institute (U.S.)NeoplasmsUnited States

Identifiers

PMID30652537
PMCPMC6668704

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.